Rosenbaum helping champion breakthrough cancer therapies at Kurome Therapeutics


Jan Rosenbaum always seemed destined for startup life. Following a 23-year stint as a scientist at Procter & Gamble, she finally stepped into the scene

Previous Bucking a trend, some firms have signed major Boston office leases recently
Next Five things to know: Lab slump impact, Flagship fund-raise, startup banks and what you're reading and watching